Você está na página 1de 5

Kepada Yth : ..........................

TINJAUAN PUSTAKA II Kamis, 11 Juli 2013

TERAPI KOMBINASI ASMA

Oleh Hendra Agus Setiawan NIM. S601007002 Pembimbing DR. Eddy Surjanto, dr., SpP(K)

PROGRAM PENDIDIKAN DOKTER SPESIALIS PULMONOLOGI DAN ILMU KEDOKTERAN RESPIRASI FK UNS/ RSUD Dr. MOEWARDI SURAKARTA 2013

DAFTAR PUSTAKA 1. Perhimpunan Dokter Paru Indonesia. Asma pedoman diagnosis dan penatalaksanaan di Indonesia. Jakarta: Perhimpunan Dokter Paru

Indonesia;2004.p.1-79. 2. Global Initiative for Asthma. Global strategy for asthma management and prevention. Vancouver: GINA Executive Committee University of British Columbia;2012.p.1-77. 3. Barnes JP. Drugs for asthma. British Journal of Pharmacology.2006;147:297303. 4. OByrne PM, Bisgaard H, Godard PP, Pistolesi M, Palmqvist M, Zhu Y, Ekstrm T, Bateman ED. Budesonide/Formoterol combination therapy as both maintenance and reliever medication in asthma. American Journal Of Respiratory And Critical Care Medicine.2005;171:129-36. 5. Mahajan S, Mehta AA. Role of cytokines in pathophysiology of asthma. iranian journal of pharmacology and therapeutics.2006;5:1-5. 6. 7. Barnes JP. Pathophysiology of asthma. Eur Respir Journal.2003;23:84-113. National Heart, Lung, And Blood Institute. Guidelines for the diagnosis and management of asthma. US Department of Health and Human Service.2007;213-79. 8. Hewrylowicz CM, Garra AO. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nature Reviews

Immunology.2005;5:271-83. 9. Carol P, Gaspard KJ. Alterations in respiratory function: disorders of gas exchange. essentials of pathophysiology. Philladelphia: Lippincott Williams & Wilkins;2004.p.376-99. 10. Monteseirin J. Neutrophils and Asthma. J Investig Allergol Clin Immunol.2009;19:340-54. 11. Marone G, Triggiani M, de Paulis A. Mast Cells and basophils : friends as well as foes in bronchiale asthma. Elseviere Trends of

Immunology.2005;25:25-31.

12.

Motuschi P. Role of leukotrienes and leukotrienens modifier in asthma. Pharmaceuticals journal.2010;3:1792-811.

13.

Zervas E, Oikonomidou E, Kainis E, Kokkala M, Petroheilou K, Gaga L. Control of asthma : review. therapy advances in respiratory disease.2008;2: 141-8. Asthma Control Test. GlaxoSmithKline. [cited 2013 May 19th]. Available from : http://www.asthma.com/assets/pdf/asthma_act_adult.pdf.

14.

15.

Bjermer L. Evaluating combination therapies for asthma : pros, cons, and comparative benefits reviews. therapy advances in respiratory

disease.2008;2:149-61. 16. Guidelines for the diagnosis and management of asthma expert panel report 2. National Institute of Health Pub.1997;97:1-98. 17. What are the combination drugs? American Thoracic Society. [cited 2013 March 2nd]. Available from: http://www.thoracic.org/clinical/copd-guidelines/for-patients/what-kind-ofmedications-are-there-for-copd/what-are-combination-drugs.php. 18. Montuschi P, Pagliari G, Fuso L. Pharmacotherapy of asthma : regular treatment or on demand? Ther Adv Respir Dis.2009;3:175-91. 19. Larsson AM, Selroos O. Advances in asthma and copd treatment: combination therapy with inhaled corticosteroids and long-acting 2agonists. Current Pharmaceutical Design.2006;12:3261-79. 20. Asthma Management Handbook. National Asthma Council.Australia.6th ed. Melbourne: NACA.2006.p.5-59 21. Worsnop C. Combination inhalers for asthma. Australian Prescriber.2006; 2:26-8. 22. Norris SL, McNally TK, Thakurta S. Drugs class review quick-relief medications for asthma. Oregon Health and Science University. Portland.2008.p.17-30. 23. Curran D, Daughaday C, Kachikian D, Littner M, Sees G. Management of asthma in children and adults. Department of Veterans Affairs Department of Defense.2009.p.16-88.

24.

Ipratropium/albuterol (salbutamol) - inhalation, Combivent. Medicinet.com. [cited 2013 March 3nd]. Available from : http://www.medicinenet.com/albuterol_and_ipratropium_oral_inhaler/article .htm

25.

Katzung BG, Masters SB, Trevor AJ. Drugs used in asthma. In: Katzung BG, editors. Basic And Clinical Pharmacology. 11th ed. McGraw Hill Lange.2009.p.380-99.

26.

Ritter JM, Lewis LD, Mant Timothy GK, Ferro A. Therapy of asthma , chronic obstructive pulmonary disease (copd). A text Book of Clinical Pharmacology and Therapeutics. 5th ed. London: Hodder Arnold;2008.p 233-44.

27.

Lindmark B. Differences in the pharmacodynamics of budesonide / formoterol and salmeterol / fluticasone reflect differences in their therapeutic usefulness in asthma. Therapeutic Advances in Respiratory Disease.2008;2.279-99.

28.

Spahn JD, Cavar R. Glucokortikoid therapy in asthma. In: Lieberman P, Anderson JA. Current clinical practice: allergic diseases: diagnosis and treatment, 3rd Ed. Totowa: Humana Press;2006.p.385-401.

29.

Chapman KR, Barnes NC, Greening AP, Jones PW, Pedersen S. Single maintenance and reliever therapy (SMART) of asthma: a critical appraisal. Thorax BMJ Journal.2010;10:1-6.

30.

Rabe KF, Pizzichini Z, Stallberg S, Romero S, Balanzat AM, Atienza T. Budesonid/formoterol in a single inhalerfor maintenance and relief in mild to moderate asthma. Chest Journal.2006;129:246-56.

Komentator

Korektor

(Yusfi Rydoka, dr)

(Dewi Makhabah,dr.) , dr)